Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression.
Yang DC, Li JM, Xu J, Oldham J, Phan SH, Last JA, Wu R, Chen CH.
Yang DC, et al. Among authors: xu j.
FASEB J. 2019 Dec;33(12):14354-14369. doi: 10.1096/fj.201901705R. Epub 2019 Oct 26.
FASEB J. 2019.
PMID: 31661644
Free PMC article.
Our data suggest MARCKS as a druggable target in pulmonary fibrosis and also provide a promising antifibrotic agent that may lead to effective IPF treatments.-Yang, D. C., Li, J.-M., Xu, J., Oldham, J., Phan, S. H., Last, J. A., Wu, R., Chen, C. …
Our data suggest MARCKS as a druggable target in pulmonary fibrosis and also provide a promising antifibrotic agent that may lead to effecti …